WHITEMED — Linagliptin Importer Profile
Pharmaceutical Importer · #1 buyer for Linagliptin · $2.5M import value · 124 shipments · MEXICO · DGFT Verified
WHITEMED is the #1 importer of Linagliptin from India with $2.5M in import value and 124 verified shipments. WHITEMED holds a 65.1% market share in Linagliptin imports based in MEXICO. The company sources from 1 verified supplier across 19 formulations shipped to 1 country.
WHITEMED — Linagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Linagliptin to WHITEMED?
Verified from 124 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BETA DRUGS LIMITED | $2.5M | 124 | 100.0% |
WHITEMED sources Linagliptin from 1 verified Indian supplier based on 124 customs records. The primary supplier is BETA DRUGS LIMITED accounting for 100.0% of imports.
How Does WHITEMED Compare to Nearest Linagliptin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | WHITEMED ★ | MEXICO | $2.5M | 124 | $20.5K |
| 2 | SUCCESS INTER LINK PTE LTD | SINGAPORE | $109.6K | 12 | $9.1K |
| 3 | TO THE- | SINGAPORE | $78.2K | 13 | $6.0K |
WHITEMED ranks #1 among 163 Linagliptin importers from India. Average shipment value of $20.5K compared to the market average of $19.2K. The closest competitors by value are SUCCESS INTER LINK PTE LTD and TO THE-.
Where Does WHITEMED Import Linagliptin To?
Destination countries from 124 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $2.5M | 124 | 100.0% |
WHITEMED imports Linagliptin to 1 country. The primary destination is MEXICO receiving 100.0% of shipments worth $2.5M.
What Linagliptin Formulations Does WHITEMED Import?
| Formulation | Value | Shipments |
|---|---|---|
| LINAGLIPTINA METFORMINA TABLETA 2 5MG 850MG LINAGLIPTIN2 5MG METFORMIN HYDROCLORIDE 850MG TABLET | $1.2M | 54 |
| LINAGLIPTINA,METFORMINA TABLETA 2.5MG,850MG LINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TABLET **** | $934.3K | 44 |
| LINAGLIPTINA,METFORMINA TABLETA 2.5MG,850MG LINAGLIPTIN2.5MG & METFORMIN HYDROCLORIDE 850MG TABLET *** | $163.9K | 7 |
| LINAGLIPTINAMETFORMINA TAB 2.5MG850MGLINGALIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB BA:59424011M:-24E:26 | $25.2K | 1 |
| LINAGLIPTINAMETFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB B:59424012M:24E:26 | $25.0K | 1 |
| LINAGLIPTINAMETFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB B:59424010M:24E:26 | $24.9K | 1 |
| LINAGLIPTINAMETFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB B:59424005M:24E:26 | $24.7K | 1 |
| LINAGLIPTINAMETFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB B:59424006M:24E:26 | $24.7K | 2 |
| LINAGLIPTINA METFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB BA:59424004M:24E:26 | $23.5K | 1 |
| LINAGLIPTINA METFORMINA TAB 2.5MG850MGLINAGLIPTIN 2.5MG & METFORMIN HYDROCLORIDE 850MG TAB BA:59424007M:24E:26 | $23.5K | 1 |
WHITEMED imports 19 distinct Linagliptin formulations from India. The top formulation is LINAGLIPTINA METFORMINA TABLETA 2 5MG 850MG LINAGLIPTIN2 5MG with 54 shipments worth $1.2M.
Regulatory Requirements: Importing Linagliptin into Mexico
What WHITEMED and other importers must comply with to import Linagliptin from India
Regulatory Authority
Federal Commission for the Protection against Sanitary Risk (COFEPRIS)
Approval Process for Generic Linagliptin
Generic drug registration under Mexican health law. Requires bioequivalence study and GMP compliance. NOM standards apply.
Typical timeline: 12–18 months
GMP Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Import Licence & Documentation
Sanitary Import Permit from COFEPRIS; import licence via Mexican customs (SAT)
Labeling & Packaging
Spanish language labeling mandatory; Mexican Official Norms (NOM) compliance
Note: Mexico requires GMP compliance per NOM-059. COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available COFEPRIS guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with COFEPRIS or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Linagliptin from India and How Much Does WHITEMED Import?
India exported $3.1M worth of Linagliptin through 1,375 shipments from 118 suppliers to 61 countries, serving 163 buyers globally. WHITEMED imports $2.5M of this total, accounting for 65.1% of India's Linagliptin exports with 124 shipments from MEXICO. This is verified from 124 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for WHITEMED's Linagliptin Imports?
WHITEMED's average Linagliptin order value is $20.5K per consignment, based on 124 shipments totaling $2.5M. WHITEMED is based in MEXICO and ranks #1 among all Linagliptin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Linagliptin to WHITEMED?
WHITEMED sources Linagliptin from 1 verified Indian supplier: BETA DRUGS LIMITED ($2.5M, 100.0%). This is based on 124 customs records.
How Does WHITEMED Compare to Other Linagliptin Importers?
WHITEMED ranks #1 among 163 Linagliptin importers from India with a 65.1% market share. The top 3 importers are WHITEMED ($2.5M), SUCCESS INTER LINK PTE LTD ($109.6K), TO THE- ($78.2K). WHITEMED processed 124 shipments from MEXICO.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Linagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Linagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: WHITEMED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as WHITEMED's capped import value divided by total capped export value for Linagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 124 individual customs records matching WHITEMED importing Linagliptin, covering 19 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 61+ countries, 163+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Linagliptin Import Data for WHITEMED
Access order-level details, pricing data, supplier connections, and competitive analysis for WHITEMED's Linagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
WHITEMED
Company Profile
Multiple products · $0 total trade · Multiple categories
WHITEMED × Linagliptin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for WHITEMED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Linagliptin. For current order-level data, contact TransData Nexus.